A Pilot Study of Long‐Term Weekly Interferon‐β Administration for Chronic Hepatitis B

Tatehiro Kagawa, Toshio Morizane, Hidetsugu Saito, Satoshi Tsunematsu, Shinichirou Tada, Naoki Kumagai, Kanji Tsuchimoto, Hitoshi Sugiura, Makio Mukai, Masaharu Tsuchiya

研究成果: Article査読

22 被引用数 (Scopus)

抄録

Interferon‐β was given weekly for 24 wk, at a dose of 3 million units, intravenously, to 10 patients with chronic hepatitis B who were serologically positive for HBsAg and HBeAg. Their condition was followed for 6 months after the end of therapy. Both serum hepatitis B virus‐associated DNA‐polymerase activity and alanine aminotransferase level became significantly lower during therapy and during the 6 months after the end of therapy than at the beginning of therapy. In five of 10 patients, the seroconversion from HBeAg positive to anti‐HBe positive had occurred by 6 months after the end of therapy, and in four of these five patients, serum alanine aminotransferase level became normal. Weekly interferon‐β administration over 6 months seems effective in inducing seroconversion and in normalizing serum alanine aminotransferase level.

本文言語English
ページ(範囲)212-216
ページ数5
ジャーナルThe American Journal of Gastroenterology
88
2
DOI
出版ステータスPublished - 1993 2月
外部発表はい

ASJC Scopus subject areas

  • 肝臓学
  • 消化器病学

フィンガープリント

「A Pilot Study of Long‐Term Weekly Interferon‐β Administration for Chronic Hepatitis B」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル